Margaret E. Gatti-Mays, M.D., M.P.H.

Margaret E. Gatti-Mays, M.D., M.P.H.
Assistant Research Physician
Laboratory of Tumor Immunology and Biology
Co-Director, Clinical Trials Group

Dr. Gatti-Mays is a Staff Clinician (physician) in the Laboratory of Tumor Immunology and Biology. Her primary interests are immuno-oncology and breast cancer. Her research is based in the clinic and is focused on the use of cancer vaccines in combination with other treatment modalities (i.e., immunotherapy agents, chemotherapy, small molecules, immune modulators) to help the immune system recognize and kill cancer cells. Dr. Gatti-Mays also has an interest in health disparities in cancer research and health literacy issues related to clinical trial participation.

Areas of Expertise
1) breast cancer 2) immunotherapy 3) therapeutic cancer vaccines 4) health literacy

Contact Info

Margaret E. Gatti-Mays, M.D., M.P.H.
Center for Cancer Research
National Cancer Institute
Building 10, Room 13N240
Bethesda, MD 20892
Ph: 240-760-6088
Fax: 301-480-8867
margaret.gatti-mays@nih.gov
Permalink

Dr. Gatti-Mays is a breast immuno-oncologist in the Laboratory of Tumor Immunology and Biology (LTIB). Her research is based in the Oncology Clinic. She focuses on tumor immunology and the development of novel immunotherapy approaches for breast cancer using therapeutic cancer vaccines, antibodies or immune modulators.

Scientific Focus Areas:
Cancer Biology, Clinical Research, Health Disparities, Immunology
View Dr. Gatti-May's PubMed Summary.

Selected Key Publications

  1. Analysis of Breast Cancer in Young Women in the Department of Defense (DOD) Database.
    Zimmer A, K Zhu, P Steeg, A Wu, ME Gatti-Mays, S Soltani, J Perkins, S Shao, D Brown, M Georg, H Hu, C Shriver, S Lipkowitz
    Breast Cancer Res Treat. Epub ahead of print, 2017. [ Journal Article ]
  2. Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations.
    Gatti-Mays ME, Redman JM, Collins JM, and Bilusic M.
    Human Vaccin Immunother. 13(11): 2561-2574, 2017. [ Journal Article ]
  3. Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety.
    Gatti-Mays ME, Venzon D, Galbo CE, Singer A, Reynolds J, Makariou E, Kallakury B, Heckman-Stoddard BM, Korde L, Isaacs C, Warren R, Gallagher A, and Eng-Wong J.
    Cancer Prev Res. 9(3): 225-233, 2016. [ Journal Article ]
  4. Toxoplasmosis Encephalitis with Immune-reconstitution Inflammatory Syndrome in an Allogeneic Stem Cell Transplant Patient: a Case Report.
    Gatti-Mays ME, Manion M, Bowen LN, Brown GT, Danner RL, Khan O, Nath A, Battiwalla M, Barrett AJ, and Ito S.
    Bone Marrow Transplant. 51(12): 1622-1624, 2016. [ Journal Article ]

Dr Gatti-Mays earned a Bachelors of Science in Biology from Trinity College (Hartford, CT) in 2005 and a Masters in Public Health in Epidemiology at the Rollins School of Public Health, Emory University (Atlanta, GA). She received a M.D. from Georgetown University School of Medicine (Washington, DC) in 2011. Following graduation in 2014 from an internal medicine residency at Medstar Georgetown University Hospital (Washington,DC), she was selected to serve as Chief Resident (2014-2015). In 2017, she completed fellowship in medical oncology at NCI and then joined the Laboratory of Tumor Immunology and Biology as a Staff Clinician. She is Co-Director of the LTIB's Clinical Trials Group.

Dr. Gatti-Mays is board certified in internal medicine and medical oncology. She is a member of the Alpha Omega Alpha Medical Honor Society.

Name Position
Andrea Burmeister PA-C Physician's Assistant (Contr)
Bonnie L. Casey Writer-Editor
Cynthia Moye Patient Care Coordinator (Contr)
Camilo Pacheco Puentes Patient Care Coordinator (Contr)